Christopher Henderson,Hynek Wichterle,Derek Oakley
申请号：
US15515679
公开号：
US20180028520A1
申请日:
2015.09.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure provides, inter alia, methods and pharmaceutical compositions for treating or ameliorating amyotrophic lateral sclerosis (ALS). Among the various aspects of the present disclosure is the provision of methods and pharmaceutical compositions for treating or ameliorating ALS. Briefly, therefore, the present disclosure is directed to a method for treating or ameliorating an effect of amyotrophic lateral sclerosis (ALS) comprising administering to a subject in need thereof a modulator of a gene selected from the group consisting of Phospholipase D1 (PLD1).
